Astrocytic contributions to Huntington's disease pathophysiology
Annals of the New York Academy of Sciences · 2023
DOI: 10.1111/nyas.14977 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, 2023. Verfasst von Baljit S Khakh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Astrocytes, Huntington Disease. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, CHDI Foundation.
Abstract (Originalsprache)
Huntington's disease (HD) is a fatal, monogenic, autosomal dominant neurodegenerative disease caused by a polyglutamine‐encoding CAG expansion in the huntingtin (HTT) gene that results in mutant huntingtin proteins (mHTT) in cells throughout the body. Although large parts of the central nervous system (CNS) are affected, the striatum is especially vulnerable and undergoes marked atrophy. Astrocytes are abundant within the striatum and contain mHTT in HD, as well as in mouse models of the disease. We focus on striatal astrocytes and summarize how they participate in, and contribute to, molecular pathophysiology and disease‐related phenotypes in HD model mice. Where possible, reference is made to pertinent astrocyte alterations in human HD. Astrocytic dysfunctions related to cellular morphology, extracellular ion and neurotransmitter homeostasis, and metabolic support all accompany the development and progression of HD, in both transgenic mouse and human cellular and chimeric models of HD. These findings reveal the potential for the therapeutic targeting of astrocytes so as to restore synaptic as well as tissue homeostasis in HD. Elucidation of the mechanisms by which astrocytes contribute to HD pathogenesis may inform a broader understanding of the role of glial pathology in neurodegenerative disorders and, by so doing, enable new strategies of glial‐directed therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, New York, USA.
- Center for Translational Neuromedicine, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
ORCID-Profile: Steven A Goldman
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- CHDI Foundation
- Novo Nordisk Fonden
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- National Institute of Neurological Disorders and Stroke
- Lundbeckfonden
Zitieren
APA
Khakh, B. S., & Goldman, S. A. (2023). Astrocytic contributions to Huntington's disease pathophysiology. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.14977
Vancouver
Khakh BS, Goldman SA. Astrocytic contributions to Huntington's disease pathophysiology. Annals of the New York Academy of Sciences. 2023. doi:10.1111/nyas.14977
BibTeX
@article{Khakh2023,
author = {Khakh, Baljit S and Goldman, Steven A},
title = {Astrocytic contributions to Huntington's disease pathophysiology},
journal = {Annals of the New York Academy of Sciences},
year = {2023},
doi = {10.1111/nyas.14977}
}
EUVIMED